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Edited by Berend WieringaAbstract Autophagy is an intracellular bulk degradation sys-
tem. We established mouse ﬁbroblast lines coupling the Tet-oﬀ
system with an Atg5/ mouse embryonic ﬁbroblast line to arti-
ﬁcially regulate autophagic ability. In the presence of doxycy-
cline (Dox), Atg5 expression was completely suppressed and
these cells were autophagy-defective. After removal of Dox,
autophagic ability was restored within 6 h. Very low levels of
Atg5 could induce an autophagy competent state. We applied
this novel system to examine the contribution of autophagy to
controlling cell size. Cell size reduction in response to starvation
was signiﬁcantly inhibited in cells unable to undergo autophagy.
The generated cell lines will be useful reagents for future mech-
anistic studies into the regulation and physiologic signiﬁcance of
autophagy.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The degradation and recycling of cytoplasmic content by
lysosomes is generically referred to as autophagy [1–4]. Three
distinct types of autophagy have been identiﬁed, macroauto-
phagy, microautophagy and chaperone-mediated autophagy,
and, among these, the molecular mechanism and physiologic
signiﬁcance of macroautophagy have been best studied. Thus,
under most circumstances, autophagy refers to macroauto-
phagy. Autophagy occurs ubiquitously in eukaryotes, and this
process is mediated by the autophagosome, a unique and spe-
cialized cellular organelle. Upon the induction of autophagy,
membrane cisternae (called isolation membranes or phago-
phores) enclose a portion of the cytoplasm, resulting in the for-
mation of the double membrane-bound autophagosome [5].
The autophagosome subsequently fuses with lysosomes to be-
come an autolysosome (autophagolysosome); within this struc-Abbreviations: TOR, target of rapamycin; PI3K, phosphatidylinositol
3-kinase; MEF, mouse embryonic ﬁbroblast; GFP, green ﬂuorescent
protein; Dox, doxycycline; PFA, paraformaldehyde; PI, propidium
iodide; FSC-H, forward scatter height
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Autophagy is thought to facilitate cell survival during peri-
ods of nutrient starvation. Autophagy is induced in yeast cells
under starvation conditions, and it is essential for cell survival
under these adverse conditions [6]. In mammals, autophagy is
upregulated following food withdrawal [7] and physiologic
starvation during the early neonatal period [8]. Autophagy is
important for maintaining the amino acid pool within cells
and the entire organism [8–10]. Additionally, throughout the
course of evolution, autophagy has gained a signiﬁcant role
in other physiological processes including regulating protein
homeostasis, clearing aggregate prone proteins, anti-aging,
degrading intracellular bacteria, tumor suppression, and regu-
lating certain types of cell death [2,4,11]. Autophagy likely has
other unidentiﬁed cellular functions, as well. Among these pos-
sible roles, autophagy may help determine cell size. Although
the volume of each autophagosome represents less than 0.1%
of total cellular volume, the short half-life and rapid genera-
tion of autophagosomes could potentially sequester a large
volume. The total degradative capacity of autophagy under
starvation conditions was estimated as 4–5%/h of total cellular
protein in perfused liver [12] or isolated hepatocytes [13], 2%/h
in embryonic stem cells [14], 0.5–1%/h in ﬁbroblasts [15], and
about 1%/h in yeast [6]. Therefore, a role for autophagy in con-
tributing to cell size reduction is a reasonable hypothesis. In-
deed, autophagy is observed in cells undergoing atrophy
such as in hepatocytes [16], muscles [17,18], and degenerating
larval tissues in Drosophila [19].
Cell size is determined by the relative rate of cell growth and
cell division [20], and both growth factor signaling (e.g. insulin)
and nutrient signaling pathways control cell growth. These two
pathways partially converge at target of rapamycin (TOR).
Genetic studies in Drosophila clearly demonstrated that cell
size is positively regulated by insulin signaling factors such
as the insulin receptor, class I PI3 kinase (PI3K), Akt and
TOR [21]. These factors also play a role in cell size regulation
in mammals [20] where S6 kinase and 4E-BP1 are two mTOR
downstream eﬀectors that are involved in cell size regulation
[22,23]. The primary cause of cell atrophy following suppres-
sion of growth factor and nutrient signaling is thought to be
a reduction in macromolecular synthesis. However, both nutri-
ent limitation and growth factor withdrawal are well known
inducers of autophagy [24]. Additionally, inhibition of TOR
signaling by rapamycin induces autophagy [25]. Since proteinblished by Elsevier B.V. All rights reserved.
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bition of autophagy is required to determine whether autoph-
agy contributes to cell size reduction.
3-Methyladenine (3-MA) is a commonly used chemical
inhibitor of autophagy. However, it generally inhibits PI3K
signaling [26] and could suppress other signaling pathways
including growth factor pathways. Furthermore, the class III
PI3K appears to have an unexpected role in amino acid-in-
duced activation of mTOR [27,28]. Thus, 3-MA is not an ideal
compound for the study of autophagy, and the use of geneti-
cally modiﬁed cells deﬁcient for Atg5 and Atg7, factors specif-
ically required for autophagosome formation, is now possible
[8,9,14]. As with any genetic knock-outs, however, cells and
organisms could adapt to the absence of these factors to con-
found any studies. Therefore, an ideal system to study autoph-
agy would be completely reversible using a single clone. In the
present study, we used Atg5/ mouse embryonic ﬁbroblasts
(MEFs) to generate cell lines with tetracycline-regulated auto-
phagic ability. We then used these cells to examine a role for
autophagy in controlling cell atrophy during starvation.2. Materials and methods
2.1. Antibodies
Anti-LC3 antibody (#1) against recombinant rat-LC3b (NO_074058)
was generated aspreviouslydescribed [29]. Polyclonal anti-greenﬂuores-
cent protein (GFP) antiserum was purchased from Molecular Probes.
Anti-mouse Atg12 (NM2) and anti-Atg5 antibodies (SO4) were previ-
ously described [14].
2.2. Plasmids
pTet-OFF, pTRE2hyg and pTRE2hyg-EGFP were purchased from
BD Biosciences Clontech. The original promoter in pTet-OFF was re-
placed with the CAG promoter and its drug resistance gene was also
replaced with the puromycin resistance gene to generate pCAG-Tet-
OFF-puro. Mouse Atg5 cDNA was inserted into the PvuII site of
pTre2hyg vector to generate pTre2hyg-mAtg5. The GFP-tagged LC3
expression vector (pCAG-GFP-LC3) was previously described [7].
2.3. Generation of Atg5 Tet-Oﬀ cells
Atg5/ MEF transformed with the SV40 large T antigen were gen-
erated previously [8]. A tetracycline-mediated reversible Atg5KO cell
line was generated in two steps. First, Atg5/ MEFs transfected with
pCAG-Tet-OFF-puro were selected in the presence of 4 lg/ml puro-
mycin. Resistant colonies were screened for stable expression of tetra-
cycline-controlled transactivator (tTA) by transient transfection with
pTRE2hyg-EGFP. Next, a positive clone was transfected with pTRE2-
hyg-mAtg5 and selected in the presence of 100 lg/ml hygromycin
(Invitrogen). Among the resistant clones, clone m5-7 was used for fur-
ther experiments. This clone was further transfected with CAG-GFP-
LC3 to obtain a cell line stably expressing the ﬂuorescent autophagos-
omal marker. The knock-out construct used to generate the Atg5/
cells contained the neomycin resistance gene, but it conferred very
weak geneticin resistance in the MEF clone. Therefore, we were able
to select GFP-LC3 stable transformants in the presence of 1 mg/ml
geneticin (GIBCO). A clone named m5-7;GFP-LC3 was used for mor-
phological analyses.
2.4. Cell culture
m5-7 and m5-7;GFP-LC3 cells were maintained in Dulbecco’s mod-
iﬁed Eagle’s medium (SIGMA) containing 10% fetal bovine serum
(FBS) with or without 10 ng/ml doxycycline hydrochloride (Dox, SIG-
MA). To restore Atg5 expression, cells maintained in Dox containing
medium were washed three times with phosphate-buﬀer saline (PBS)
and cultured in Dox free medium. For starvation treatment, cells were
washed once with PBS and incubated in amino acid free DMEM
(kindly provide by Ajinomoto Co.) without FBS.2.5. Cell lysis and immunoblot
Cells were washed once with PBS and lysed in lysis buﬀer (1% Tri-
ton-100, 50 mM Tris–HCl [pH 7.5], and 150 mM NaCl) supplemented
with protease inhibitors (Roche) and 1 mM phenylmethanesulfonyl
ﬂuoride (PMSF). 6· SDS sample buﬀer was then added and samples
were boiled for 5 min. Thirty micrograms of protein per lane was sep-
arated by SDS–polyacrylamide gel electrophoresis and transferred to
polyvinylidene diﬂuorude membrane (Millipore). Immunoblot analysis
was performed with the indicated antibodies and developed using an
enhanced chemiluminescence (ECL) system (Amersham Pharmacia
Biotech).
2.6. Fluorescence microscopy
m5-7;GFP-LC3 cells grown on cover slips were washed with PBS
three times and ﬁxed in 3% paraformaldehyde (PFA) in PBS for
15 min at room temperature. Cells were examined under a ﬂuorescence
microscope (Olympus IX81) equipped with CCD cameras (ORCA ER,
Hamamatsu Photonics). To quantify the amount of GFP-LC3 dots,
the dot signals were extracted using the Top Hat program of Meta
Morph Series Version 6 (Molecular Device), and the total area of
the dots was calculated.
2.7. Cell size assay
Cells were trypsinized, ﬁxed for over 2 h in cold 70% ethanol, and
washed with PBS once. Cells were then stained with propidium iodide
(PI) staining solution (50 lg/ml PI (SIGMA) and 50 lg/ml RNase
(Roche Diagnostics) in PBS) for 30 min at 37 C. Cell size was ana-
lyzed using a FACSCalibur (Becton Dickinson). Mean forward scatter
height (FSC-H) was determined on G1-gated cells identiﬁed by PI ﬂuo-
rescence (FL2-A). All statistical analyses used a Student’s t test.3. Results
3.1. Successful generation of Atg5 Tet-Oﬀ cells
We used Atg5/ MEFs to generate cells in which Atg5
expression is regulated by the presence or absence of tetracy-
cline. The Tet-oﬀ system is widely used to suppress gene
expression by cell treatment with tetracycline or Dox [30].
We introduced two regulator gene cassettes, CAG-tTA and
TRE-mAtg5, into an immortalized MEF clone and generated
an Atg5 Tet-oﬀ cell line named m5-7. The presence of Dox in
the culture media should suppress Atg5 expression, and Dox
removal should allow Atg5 expression. Since Atg5 is an accep-
tor molecule of the ubiquitin-like protein Atg12, Atg5 is de-
tected almost exclusively as an Atg12–Atg5 conjugate within
cells. In m5-7 cells cultured without Dox, the degree of
Atg12–Atg5 expression was comparable to wild-type cells
(Fig. 1, lane 2). A very faint band corresponding to Atg5
monomer is occasionally detected in both m5-7 and wild-type
cells. Anti-Atg5 and anti-Atg12 antibodies detect the same spe-
cies [31], and we used an anti-Atg12 antibody for the detection
of Atg12–Atg5 in this paper.
The Atg12–Atg5 conjugate is required for the proper func-
tion of the LC3 ubiquitin-like conjugation system [14]. LC3
is a mammalian homolog of yeast Atg8, and it is present as
two forms [29]. Nascent LC3 is processed by Atg4 homologs
to LC3-I, a cytosolic form, and LC3-I is then conjugated
with phosphatidylethanolamine in an Atg12–Atg5 dependent
manner to generate LC3-II [32]. LC3-II associates with the
autophagosomal membrane, and LC3-II levels correlate with
the number of autophagosomes. In m5-7 cells, the conver-
sion of LC3-I to LC3-II following starvation was also re-
stored (Fig. 1, lane 2), suggesting that autophagosome
formation occurs normally in m5-7 cells if cultured in the
absence of Dox.
Fig. 1. Dose dependent suppression of autophagy in m5-7 cells by
Dox. Wild-type MEFs (lane 1) and m5-7 cells (lane 2–8) were cultured
in DMEM with 10% FBS containing the indicated concentrations of
Dox for 4 days. Cells were incubated with DMEM without amino
acids and serum for the ﬁnal 1 h. The lysates were analyzed by
immunoblotting using anti-LC3 antibody (#1) and anti-Atg5 antibody
(SO4).
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m5-7 cells following Dox addition, m5-7 cells were cultured
with indicated concentrations of Dox for four days. We ob-
served a dose-dependent reduction in the amount of the
Atg12–Atg5 conjugate (Fig. 1). The Atg12–Atg5 conjugate
was not detected by immunoblotting if m5-7 cells were cul-
tured with >1.0 ng/ml of Dox. Under these conditions, LC3-
II generation was also completely suppressed (Fig. 1, lane
5–8). In cells cultured in 0.1 ng/ml Dox the amount of
Atg12–Atg5 was reduced to less than one tenth that of wild-
type cells, but LC3 conversion occurred almost normally.
Thus, very low levels of Atg12–Atg5 could be suﬃcient for
autophagy. Since more than 1 ng/ml of Dox was suﬃcient to
completely suppress autophagic activity, we culture m5-7 cells
in 10 ng/ml of Dox to maintain the Atg5 deﬁcient state.Fig. 2. Four days of Dox treatment is needed to suppress autophagy in m5
containing with 10 ng/ml of Dox for the indicated times. Cells were incubat
lysates were analyzed by immunoblotting using anti-LC3 antibody and a
described in panel A. Cells were ﬁxed with 3% PFA and analyzed by ﬂuores3.2. Dox treatment for 4 days is required for full inhibition of
autophagy
We next wished to determine the duration of Dox-treatment
needed to fully inhibit autophagy. When m5-7 cells were grown
in the presence of 10 ng/mLDox, there was a decrease in Atg12–
Atg5 expression with time, and Atg12–Atg5 conjugate levels
were not detectable after three days (Fig. 2A). Additionally, un-
der nutrient rich culture conditions, no LC3-II was seen at day 3
(data not shown). However, under starvation conditions, some
LC3 conversion was detected after 3 days of culture in Dox, but
LC3 conversion was completely inhibited by day 4 (Fig. 2A).
We also examined autophagosome formation microscopi-
cally. m5-7 cells were engineered to stably express GFP-LC3,
a commonly used ﬂuorescent autophagosome marker. In the
resulting clone called m5-7;GFP-LC3, many GFP-LC3 dots
were observed under starvation conditions when cells were cul-
tured without Dox (Fig. 2B, 0 d). The number of GFP-LC3 dots
decreased following Dox addition. On day 4, dot formation was
completely inhibited and GFP-LC3 was observed exclusively in
the cytosol (Fig. 2B). Taken together, these results indicate that
treatment of cells with Dox for 4 days is needed to fully suppress
autophagy in m5-7 and m5-7;GFP-LC3 cells.
3.3. Autophagy is rapidly restored in m5-7 cells after Dox
withdrawal
The addition of Dox clearly inhibited autophagosome for-
mation after 4 days, and we next wished to determine the
kinetics of autophagy induction after Dox withdrawal.
Atg12–Atg5 conjugate was detected by immunoblotting by
24 h after Dox removal, but LC3 conversion occurred within
4 h (including the ﬁnal 1-h starvation period) after Dox re-
moval and reached a maximal level at 8 h (Fig. 3A). Addition-
ally, signiﬁcant number of GFP-LC3 dots began to appear as
early as 4 h (including the ﬁnal 1-h starvation period) after
Dox removal (Fig. 3B and C). These data suggest that an 8-
h incubation without Dox could restore autophagosome for-
mation almost completely, despite very low levels of Atg12–
Atg5 expression.-7 cells. Panel A: m5-7 cells were cultured in DMEM with 10% FBS
ed with DMEM without amino acids and serum for the ﬁnal 2 h. The
nti-Atg12 antibody. Panel B: m5-7;GFP-LC3 cells were cultured as
cence microscopy. Bars, 20 lm.
Fig. 3. Rapid restoration of Atg5 expression and autophagosome formation by removal of Dox. Panel A: m5-7 cells were pre-cultured for one week
in the presence of 10 ng/ml of Dox to completely suppress autophagic ability. Cells were then cultured in the absence of Dox for the indicated times.
At the end of each incubation period, cells were subjected to 1-h starvation. The lysates were analyzed by immunoblotting using anti-LC3 and anti-
Atg12 antibodies. Panel B: m5-7;GFP-LC3 cells were treated as described in panel A. Cells were ﬁxed with 3% PFA and analyzed by ﬂuorescence
microscopy. Bars, 20 lm. Panel C: Quantiﬁcation of GFP-LC3 dots in m5-7;GFP-LC3 cells cultured as in panel B. The ratio of the total area of
GFP-LC3 dots to the total cellular area is shown as percentage. Values represent means ± S.E. of more than 10 cells.
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induction in m5-7 cells
The conversion of LC3-I to LC3-II and the appearance of
GFP-LC3 dots suggest autophagosome formation, but these
events do not necessarily indicate autophagic degradation.
LC3 is localized on both the inner and outer membranes of
autophagosomes, and outer membrane associated LC3 is
thought to dissociate after autophagosome-lysosome fusion
while inner membrane associated LC3 is degraded by the lyso-
somal enzymes [14,29]. GFP-LC3 essentially follows the same
process. However, if GFP-Atg8 is expressed in yeast cells, pro-
cessed GFP accumulates in the vacuole in an autophagy-
dependent manner because GFP is stable and relatively
resistant to vacuolar enzymes [33]. Therefore, we examined
the generation of autophagolysosomally processed GFP in
m5-7;GFP-LC3 cells to measure the autophagy ﬂux. In the
absence of Dox, we detected some cleaved free GFP, and freeFig. 4. Restoration of autophagy ﬂux following Dox removal. m5-7;GFP-LC
starvation. The lysates were prepared at the indicated times and analyze
immunoblotting using anti-LC3, anti-GFP antibodies. The positions of GFPGFP levels increased in a time dependent manner after cell
starvation. The time course of GFP cleavage correlated well
with LC3 conversion, and it may be a more sensitive readout
for autophagy induction (Fig. 4). Free GFP also accumulated
at later time points under nutrient rich conditions, and this
likely reﬂects basal levels of autophagy. Taken together, these
data indicate that GFP-LC3 is delivered from the cytosol to
lysosomes in m5-7 cells, and suggests that these cells perform
physiologic autophagy after the removal of Dox. Additionally,
given the sensitivity of anti-GFP reagents, the generation of
cleaved GFP fragments from GFP-LC3 is a useful readout
for autophagy induction in mammalian cells.
3.5. Autophagy is partially involved in cell size reduction during
nutrient starvation
We next used the generated m5-7 cells to study the role of
autophagy in controlling cell size during starvation. As illus-3 cells were cultured as described in Fig. 3 with or without ﬁnal a 2-h
d for LC3 conversion and cleavage of GFP-LC3 into free GFP by
-LC3-I, GFP-LC3-II and the cleaved GFP fragment are indicated.
Fig. 5. Autophagy partially accounts for cell size reduction during nutrient starvation. Panel A: Schematic diagram of the experiments for cell size
analysis. m5-7 cells pre-cultured with 10 ng/ml of Dox for a week were split and cultured for 24 h in the absence or presence of Dox. Cells were then
cultured in DMEM without amino acids and serum for 10 h. Cell samples were prepared at the times indicated by white arrows. Panel B: Cell cycle
proﬁles of m5-7 cells before and after 10-h starvation. Cells were ethanol-ﬁxed and the cellular DNA content was determined by PI staining and ﬂow
cytometry. Proportions of G1, S, and G2/M phase cells are shown. ST, starvation. Panel C: Representative FSC-H histogram of G1 phase m5-7 cells.
Cell samples were prepared before and after starvation treatment as indicated in panel A. Gray shading: cells cultured without Dox, black line: cells
cultured with Dox. Panel D:Mean FSC-H with standard error (error bar) of G1 phase cells prepared as in panel A. Student’s t tests were performed
for statistical analysis. *, P < 0.05. n = 3 for wild-type cells, n = 5 for m5-7 cells.
N. Hosokawa et al. / FEBS Letters 580 (2006) 2623–2629 2627trated in Fig. 5A, m5-7 cells were maintained in an autoph-
agy-deﬁcient state and then split into media with or without
Dox. After 24 h, both groups were subjected to a 10-h per-
iod of starvation. The 10-h starvation did not substantially
aﬀect the cell cycle proﬁles (Fig. 5B), and the inhibition of
autophagic ability had no eﬀect on cell cycle progression
(data not shown). We evaluated cell size by measuring the
mean FSC-H using a standard ﬂow cytometry technique.
To exclude potentially confounding cell cycle eﬀects, we ana-
lyzed the FSC-H only on G1-gated cells following PI stain-
ing. In cells cultured in the presence or absence of Dox, cell
size was signiﬁcantly reduced by nutrient starvation (Fig. 5C
and D). However, the reduction in cell size in cells unable to
undergo autophagy was signiﬁcantly less than that seen in
autophagy competent m5-7 cells cultured without Dox
(Fig. 5D). These eﬀects were not observed in a non-engi-
neered wild-type MEF clone (Fig. 5D). Thus, our data sug-
gest that autophagy is partially responsible for controlling
cell size under conditions of nutrient starvation.4. Discussion
The Atg5-inducible cell line generated in this study has sev-
eral signiﬁcant advantages over previous models for functional
studies of autophagy. The single m5-7 clone can adopt either a
wild-type or Atg5 deﬁcient phenotype simply by controllingDox addition, and this avoids diﬃculties with clonal variation.
Clonal variation is a particular problem in immortalized clones
and cell lines. Additionally, because the m5-7 cells are based on
an Atg5 deﬁcient cell line, complete and speciﬁc suppression of
autophagy can be achieved. This represents a substantial ad-
vance over chemical inhibitors and RNAi-mediated gene sup-
pression. Finally, the restoration of autophagy in m5-7 cells is
very rapid, and the kinetics of autophagy induction in these
cells will help minimize cellular adaptations to Atg5 deﬁciency,
a particular concern when we use irreversible KO cells. In these
cells, other degradation systems such as chaperone-mediated
autophagy might be upregulated.
Having generated this valuable reagent, we determined that
autophagy partially controls cell atrophy during starvation,
but a possible role for authophagy in controlling cell size under
normal conditions remains unclear. Since autophagy constitu-
tively occurs at low levels under nutrient rich conditions, defec-
tive autophagy could also aﬀect cell size. We observed a
tendency that size of m5-7 cells became smaller after restora-
tion of autophagy even under non-starvation conditions,
although there was no signiﬁcant diﬀerence (Fig. 5D). Addi-
tionally, mice with a liver-speciﬁc deﬁciency in Atg7 exhibit en-
larged hepatocytes and hepatomegaly [9]. In contrast, the
growth of Atg5/ and Atg7/ is slightly stunted [8,9], but cell
size was not examined in these animals. Compensatory re-
sponses may mask any role for autophagy in controlling cells
size in these animals.
2628 N. Hosokawa et al. / FEBS Letters 580 (2006) 2623–2629We observed eﬃcient autophagy even in the presence of
undetectable levels of the Atg12–Atg5 conjugate. This obser-
vation clearly explains the normal phenotype of Atg5+/ mice
[8], and similar observations were made in yeast. Substitution
of C-terminal Gly-186 with Ala in yeast Atg12 substantially
decreased Atg5 conjugation eﬃciency resulting in very low
Atg12–Atg5 conjugate levels [34]. Nonetheless, cells expressing
this mutant construct exhibit normal autophagic activity and
aminopeptidase I transport (the cytoplasm-to-vacuole target-
ing pathway). Why are such small amounts of Atg12–Atg5 suf-
ﬁcient? In both yeast and mammalian cells, most Atg12–Atg5
conjugate resides in the cytosol and only a small fraction asso-
ciates with the isolation membrane [14,35]. Therefore, the
number of Atg12–Atg5 conjugates functioning in autophago-
some formation may be very small. This is particularly impor-
tant to consider when performing RNAi studies. Since Atg5
has no redundant homologs in mammals, it is often chosen
as an RNAi target. Our results suggest that nearly complete
suppression of Atg5 expression is needed to fully inhibit
autophagy.
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